Rouba Ead Pharmd

Rouba Ead PharmD serves as the Head of US Patient Safety/Pharmacovigilance Operations at Galderma, a position held since May 2025. Rouba's previous roles include Director of Global Patient Safety & Pharmacovigilance, Audits and Inspections at Takeda from January 2022 to May 2025, and various leadership positions in Pharmacovigilance at Bausch Health Companies Inc. from August 2016 to January 2022. Earlier career experience includes Pharmacovigilance Manager for NewBridge Pharmaceuticals and researcher at the US FDA. Rouba's academic qualifications encompass a Master's degree in Global Pharmacovigilance & Clinical Regulations from Temple University, a Doctorate in Clinical Pharmacy from Midwestern University, a Diploma in Epidemiology from ISPED Victor Segalen, and a BS in Pharmacy from Massachusetts College of Pharmacy and Health Sciences.